Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Non-transfusion-dependent thalassemia

Non-transfusion-dependent thalassemia

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Non-transfusion-dependent thalassemia

4 trials tracked for Non-transfusion-dependent thalassemia: 1 in phase 3 or 4.

4Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 2 3
  1. Phase 4 Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia Completed
  2. Phase 2 Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study Completed
  3. Phase 2 Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet Completed
  4. Phase 2 Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Retrospective US claims analysis examines complications in non-transfusion-dependent thalassemia
Hematology Cohort
Retrospective US claims analysis examines complications in non-transfusion-dependent thalassemia Study examines complications and treatments in adults with non-transfusion-dependent thalassemia
A retrospective observational cohort study of US adults with α- or β-non-transfusion-dependent thalassemia (NTDT) used claims data to examin…
Adults in the US with non-transfusion-dependent thalassemia face specific complications and treatment patterns that differ from matched cont…
Frontiers Mar 31, 2026